Shriniwasa Proteins Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 05-01-2025
- Paid Up Capital ₹ 25.00 Cr
as on 05-01-2025
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 164.00 Cr
as on 05-01-2025
- Revenue 1899.75%
(FY 2022)
- Profit 7977.08%
(FY 2022)
- Ebitda 19128.74%
(FY 2022)
- Net Worth 1477704.74%
(FY 2022)
- Total Assets 2846.18%
(FY 2022)
About Shriniwasa Proteins
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 25.00 Cr.
The company currently has active open charges totaling ₹164.00 Cr.
Pramod Jadhav, Prashant Wagh, Anuj Shingare, and One other member serve as directors at the Company.
- CIN/LLPIN
U15490MH2020PTC352000
- Company No.
352000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalna, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shriniwasa Proteins?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivam Singare  | Director | 16-Dec-2020 | Current |
| Pramod Jadhav | Director | 16-Dec-2020 | Current |
| Prashant Wagh | Director | 17-Jan-2021 | Current |
| Anuj Shingare | Director | 16-Dec-2020 | Current |
Financial Performance of Shriniwasa Proteins.
Shriniwasa Proteins Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1899.75% increase. The company also saw a substantial improvement in profitability, with a 7977.08% increase in profit. The company's net worth Soared by an impressive increase of 1477704.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shriniwasa Proteins?
In 2022, Shriniwasa Proteins had a promoter holding of 50.02% and a public holding of 49.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹164.00 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 164.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2021 | State Bank Of India | ₹82.00 Cr | Open |
| 24 Dec 2021 | State Bank Of India | ₹82.00 Cr | Open |
How Many Employees Work at Shriniwasa Proteins?
Shriniwasa Proteins has a workforce of 57 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shriniwasa Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shriniwasa Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
